NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 82 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $149,435 | -48.7% | 139,659 | +95.5% | 0.00% | -100.0% |
| Q1 2023 | $291,487 | -41.2% | 71,443 | -27.7% | 0.00% | -50.0% |
| Q4 2022 | $495,810 | +46.3% | 98,767 | +281.1% | 0.00% | 0.0% |
| Q3 2022 | $339,000 | -42.6% | 25,914 | -33.1% | 0.00% | -33.3% |
| Q1 2022 | $591,000 | +224.7% | 38,747 | +277.4% | 0.00% | – |
| Q4 2021 | $182,000 | -46.2% | 10,266 | -36.1% | 0.00% | -100.0% |
| Q3 2021 | $338,000 | -23.2% | 16,076 | -27.9% | 0.00% | -50.0% |
| Q2 2021 | $440,000 | -37.1% | 22,296 | -7.3% | 0.00% | -50.0% |
| Q1 2021 | $699,000 | +11.8% | 24,039 | +16.6% | 0.00% | -20.0% |
| Q4 2020 | $625,000 | +7.2% | 20,618 | -30.2% | 0.01% | -44.4% |
| Q2 2020 | $583,000 | – | 29,525 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 18,136,735 | $19,406,306 | 12.88% |
| StepStone Group LP | 1,573,357 | $1,683,492 | 0.38% |
| EcoR1 Capital, LLC | 6,435,518 | $6,886,004 | 0.23% |
| Euclidean Capital LLC | 1,984,336 | $2,123,240 | 0.23% |
| Boxer Capital, LLC | 500,000 | $535,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 213,676 | $229 | 0.02% |
| Jasper Ridge Partners, L.P. | 303,492 | $324,736 | 0.02% |
| Carson Advisory Inc. | 15,850 | $16,960 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 51,176 | $54,758 | 0.01% |
| Parkwood LLC | 68,314 | $73 | 0.01% |